COVID-19: Favipiravir shows hope in Mumbai trial

While the WHO last week recommended that antiviral remdesivir not be used for severely ill Covid-19 patients, Mumbai doctors published the first scientific study showing another antiviral, favipiravir, reduced the "cure time" in mild cases.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3nQYxv4
via IFTTT